Skip to main content
Advertisement
  • Loading metrics

PLoS Medicine Issue Image | Vol. 16(4) May 2019

Addressing critical needs in the fight to end tuberculosis with innovative tools and strategies

The leading infectious cause of death worldwide, tuberculosis demands an urgent response that will realistically enable the disease's elimination. Despite increases in funding for TB prevention and care in recent years, progress towards TB elimination still lags behind WHO- and UN-endorsed targets, underscoring the need for novel approaches.

This month in PLOS Medicine we are proud to launch a Special Issue on New Tools and Strategies for Tuberculosis Diagnosis, Care, and Elimination, guest edited by Claudia Denkinger, Richard Chaisson, and Mark Hatherill. This Special Issue includes high-quality research focusing on novel biomarkers and diagnostic techniques, development of new treatments and vaccines, and testing of new strategies to find and treat tuberculosis and enhance adherence to therapy.

In this issue's Editorial, the Guest Editors highlight some of the research publishing in this special issue and how these studies focusing on discovery, clinical trials and implementation research collectively add to the prospects for reaching the EndTB targets of the WHO by 2035.

Image Credit: GDJ, Pixabay and NIAID, Flickr

thumbnail
Addressing critical needs in the fight to end tuberculosis with innovative tools and strategies

The leading infectious cause of death worldwide, tuberculosis demands an urgent response that will realistically enable the disease's elimination. Despite increases in funding for TB prevention and care in recent years, progress towards TB elimination still lags behind WHO- and UN-endorsed targets, underscoring the need for novel approaches.

This month in PLOS Medicine we are proud to launch a Special Issue on New Tools and Strategies for Tuberculosis Diagnosis, Care, and Elimination, guest edited by Claudia Denkinger, Richard Chaisson, and Mark Hatherill. This Special Issue includes high-quality research focusing on novel biomarkers and diagnostic techniques, development of new treatments and vaccines, and testing of new strategies to find and treat tuberculosis and enhance adherence to therapy.

In this issue's Editorial, the Guest Editors highlight some of the research publishing in this special issue and how these studies focusing on discovery, clinical trials and implementation research collectively add to the prospects for reaching the EndTB targets of the WHO by 2035.

Image Credit: GDJ, Pixabay and NIAID, Flickr

https://doi.org/10.1371/image.pmed.v16.i04.g001